Corvus Pharmaceuticals (CRVS) Long-Term Investments (2020 - 2026)
Corvus Pharmaceuticals (CRVS) recorded Long-Term Investments of $15.11 million in Q2 2026, up 28.1% from $11.79 million a year earlier and up 43.9% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Long-Term Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, Corvus Pharmaceuticals reported Long-Term Investments of $10.99 million, down 12.4% from FY2024.
- Annual Long-Term Investments has declined for five straight years, with a five-year compound annual growth rate of -21.6% (FY2020 to FY2025).
- Across earlier years, Long-Term Investments came in at $12.54 million in FY2024 (-22.2%), $16.12 million in FY2023 (-26.3%), $21.88 million in FY2022 (-36.2%) and $34.27 million in FY2021 (-7.9%).
- The Q2 2026 figure is the highest quarterly Long-Term Investments since Q3 2024.
- On a year-over-year basis, Long-Term Investments rose in 1 of the last eight quarters, with an average decline of 12.9%.
- Peak year-over-year performance for Long-Term Investments in the last five years was growth of 28.1% in Q2 2026, against a decline of 40.3% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $10.5 million (Q1 2026), $10.99 million (Q4 2025) and $11.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Corvus Pharmaceuticals | 969.07 Mn | 457.51 Mn | - | 15.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.11 Mn |
| Mar 31, 2026 | 10.50 Mn |
| Dec 31, 2025 | 10.99 Mn |
| Sep 30, 2025 | 11.53 Mn |
| Jun 30, 2025 | 11.79 Mn |
| Mar 31, 2025 | 12.06 Mn |
| Dec 31, 2024 | 12.54 Mn |
| Sep 30, 2024 | 15.19 Mn |
| Jun 30, 2024 | 15.40 Mn |
| Mar 31, 2024 | 16.07 Mn |
| Dec 31, 2023 | 16.12 Mn |
| Sep 30, 2023 | 17.07 Mn |
| Jun 30, 2023 | 18.02 Mn |
| Mar 31, 2023 | 20.23 Mn |
| Dec 31, 2022 | 21.88 Mn |
| Sep 30, 2022 | 25.91 Mn |
| Jun 30, 2022 | 30.18 Mn |
| Mar 31, 2022 | 33.37 Mn |
| Dec 31, 2021 | 34.27 Mn |
| Sep 30, 2021 | 36.33 Mn |
API Access
Corvus Pharmaceuticals Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();